COVID-19 Vaccination Acceptance and Hesitancy in Healthcare Workers and the General Population: A Systematic Review and Policy Recommendations.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
28 Aug 2024
Historique:
received: 28 05 2024
revised: 10 07 2024
accepted: 16 07 2024
medline: 29 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

The COVID-19 pandemic challenged the scientific community to find and develop a vaccine to fight the disease. However, problems with achieving high vaccine coverage have emerged, even among high-risk groups such as healthcare workers (HCWs). The objective of this study is to examine factors that influence HCW's and the general population's adherence to COVID-19 vaccination and national policies to vaccinate HCWs and other target groups. This study implemented a systematic review. The eligibility criterion for inclusion was being a HCW, target population for COVID-19 vaccination, or general population. Vaccination was the target intervention, and the COVID-19 pandemic was the context. We selected publications published between 1 January 2020 and 31 March 2022. Qualitative synthesis used a meta-aggregation approach. Nineteen articles were included in the review, with study samples varying from 48 to 5708 participants. Most of the evidence came from cross-sectional and qualitative studies. The main findings were related to vaccine hesitancy rather than acceptance. Factors associated with HCW vaccine hesitancy included subjective feelings such as safety concerns, rapid vaccine development, and insufficient testing. Countries have adopted few public policies to address this problem, and the main concern is whether to enforce vaccination and the extent to which measures are legal. The quality of the evidence base remains weak. Skepticism, mistrust, and hesitancy toward vaccination are global issues that can jeopardize vaccination coverage.

Identifiants

pubmed: 39338017
pii: ijerph21091134
doi: 10.3390/ijerph21091134
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Systematic Review Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : World Health Organization
ID : 2021/1175760-0
Pays : International

Auteurs

Alessandra Pereira da Silva (A)

Instituto Nacional do Câncer, Rua Marquês de Pombal 125, 12° andar Centro, Rio de Janeiro 20230-240, RJ, Brazil.

Luciana Ribeiro Castaneda (LR)

Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rua São Francisco Xavier, 524-7° andar, Blocos D e E-Maracanã, Rio de Janeiro 20550-013, RJ, Brazil.

Ana Paula Cavalcante de Oliveira (AP)

Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rua São Francisco Xavier, 524-7° andar, Blocos D e E-Maracanã, Rio de Janeiro 20550-013, RJ, Brazil.

Inês Fronteira (I)

Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa, Rua da Junqueira 100, 1349-008 Lisboa, Portugal.

Isabel Craveiro (I)

Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa, Rua da Junqueira 100, 1349-008 Lisboa, Portugal.

Leila Senna Maia (LS)

Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rua São Francisco Xavier, 524-7° andar, Blocos D e E-Maracanã, Rio de Janeiro 20550-013, RJ, Brazil.

Raphael Chança (R)

Instituto Nacional do Câncer, Rua Marquês de Pombal 125, 12° andar Centro, Rio de Janeiro 20230-240, RJ, Brazil.

Mathieu Boniol (M)

Health Workforce Department, World Health Organization, Av. Appia 20, 1202 Geneva, Switzerland.

Paulo Ferrinho (P)

Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa, Rua da Junqueira 100, 1349-008 Lisboa, Portugal.

Mario Roberto Dal Poz (MR)

Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rua São Francisco Xavier, 524-7° andar, Blocos D e E-Maracanã, Rio de Janeiro 20550-013, RJ, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH